More early retirements at Mitsubishi Tanabe
This article was originally published in Scrip
Executive Summary
Another 217 people at Mitsubishi Tanabe Pharma(MTP) in Japan are to take early retirement from the company on September 30th. The option was offered to all employees aged between 40 and less than 60 who had been with the firm (or its pre-merger predecessors) for over 10 years. Those taking it up will receive special allowances and support in addition to standard retirement benefits, for which MTP said it would book ¥3.9 billion ($35.9 million) in one-off costs in the second quarter ending September 30th. There had already been several similar rounds of employee reductions as part of MTP's creation from the merger of Mitsubishi Pharma and Tanabe, completed last October.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Teva’s immunology biosimilar launches; Intra-Cellular’s promising depression data; Phase III sleep apnea win for Lilly’s tirzepatide; an interview with Viking’s CEO; and China looks to define innovative drugs.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.